3 results match your criteria: "Center for Spinal Restoration[Affiliation]"
Safety and Efficacy of Platelet Rich Plasma for Treatment of Lumbar Discogenic Pain: A Prospective, Multicenter, Randomized, Double-blind Study.
Pain Physician
January 2022
Neurological Associates - The Interventional Group, USA, Los Angeles, CA; Department of Neurology, University of California, Los Angeles, CA.
Background: Interventions for chronic discogenic spine pain are currently insufficient in lowering individual patient suffering and global disease burden. A 2016 study of platelet rich plasma (PRP) for chronic discogenic pain previously demonstrated clinically significant response among active group patients compared with controls.
Objectives: To replicate the previous research to move this intervention forward as a viable option for patient care.
Editors' Introduction: Biologics and Regenerative Medicine in Intervertebral Disc Regeneration and Spinal Fusion.
Int J Spine Surg
April 2021
The Spine Institute Center for Spinal Restoration, Santa Monica, California.
Allogeneic mesenchymal precursor cells (MPCs) combined with an osteoconductive scaffold to promote lumbar interbody spine fusion in an ovine model.
Spine J
March 2016
The Spine Institute, Center for Spinal Restoration, 2811 Wilshire Blvd., Suite 850, Santa Monica, CA 90403, USA.
Background: Advances in immunomagnetic cell sorting have enabled isolation and purification of pleuripotent stem cells from marrow aspirates and have expanded stem cell therapies to include allogeneic sources.
Purpose: This study aimed to determine the safety and efficacy of allogeneic mesenchymal precursor cells (MPCs) combined with an osteoconductive scaffold in lumbar interbody spinal fusion using an ovine model.
Study Design: Thirty-two skeletally mature ewes underwent a single-level interbody fusion procedure using a Polyetheretherketone fusion cage supplemented with either iliac crest autograft (AG) or an osteconductive scaffold (Mastergraft Matrix, Medtronic, Memphis, TN, USA) with 2.